ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea
· Delayed Price · Currency is KRW 5,130.00
+20.00 (0.39%)
At close: Aug 13, 2025, 3:30 PM KST
ImmuneOncia Therapeutics Revenue
In the year 2024, ImmuneOncia Therapeutics had annual revenue of 654.54M KRW with 495.04% growth.
Revenue
654.54M
Revenue Growth
+495.04%
P/S Ratio
579.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
379.14B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| HD Hyundai Heavy Industries | 15.32T |